Our 2D and 3D models showed results similar to those reported by previous studies that involved assessing gene expression responses to IFNγ and TNFα treatment in in vitro IBD models and in vivo IBD patients (Figures 1, 5, Supplementary Figure 4). This evidence concerns the gene IFNG and inflammatory bowel disease.